VBIO

← Markets

VBIOValion Bio, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 27
7:30 AMstocktitan.netValion Bio Announces Reverse Stock Split
Wed, Aug 12
9:17 AMinvestorshub.advfn.comValion Bio Advances Government-Funded Entolimod Radiation Injury Studies With Data Expected in Early Fall
8:29 AMYahooValion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
Mon, Jul 20
12:05 PMYahooWorld-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market
Tue, Jul 14
6:45 AMYahooValion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion
Thu, Jun 25
6:45 AMYahooAFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARS
Thu, Jun 11
6:45 AMYahooValion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures
Tue, May 19
3:38 PMYahooVALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME
Thu, May 14
3:30 PMYahooValion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform
3:05 PMYahooVALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Mon, May 11
7:01 AMYahooValion Bio to Report First Quarter 2026 Financial Results on May 14, 2026
Wed, May 6
7:08 AMYahooValion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™